Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News MMTEC Inc MTC

Technology Software - Application
Mmtec Inc is a China-based company primarily engaged in asset management services based on platforms. The Company is principally engaged in providing complete suite trading solutions, including fund creation, distribution, custody, trading and settlement services, to help these financial institutions accelerate their integration into overseas markets. The Company's systems include ETN counter... see more

Recent & Breaking News (NDAQ:MTC)

Healogics® Eighth Annual Wound Care Awareness Week Focuses on the Growing Need for Wound Care

PR Newswire June 2, 2021

ArchCare Extends Contract with Tabula Rasa HealthCare for Medication Safety, Efficacy, and Adherence Services

PR Newswire June 2, 2021

Phase 3 Maintenance Results Show Patients with Crohn's Disease Receiving Risankizumab (SKYRIZI®) Achieved Endoscopic Response and Clinical Remission at One Year

PR Newswire June 2, 2021

I-Mab to Hold Investor Call to Present In-Depth Phase 1 Clinical Data on Highly Differentiated CD73 Antibody Uliledlimab

PR Newswire June 2, 2021

Johnson & Johnson Vision Expands "Sight For Kids" Program to Bring Eye Care to More Children and Unveils New "Vision for Good" Community Impact Report

PR Newswire June 2, 2021

New Phase 3b Psoriatic Arthritis (PsA) Data Show First-in-Class TREMFYA® (guselkumab) Achieved Robust Joint Symptom Improvement and Complete Skin Clearance in Patients with Inadequate Response to Tumor Necrosis Factor Inhibition (TNFi-IR)

PR Newswire June 2, 2021

Poseida Therapeutics Announces Virtual 2021 Annual Meeting of Stockholders

PR Newswire June 2, 2021

PharmAbcine to Present at the BIO Digital International Convention 2021

PR Newswire June 2, 2021

CardioFocus Announces Agreement with China Grand Pharmaceutical to Bring HeartLight X3 System to China

PR Newswire June 2, 2021

Indivumed Launches the nRavel(TM) AI Platform for Cancer Research and Drug Development

PR Newswire June 2, 2021

NLS Pharmaceutics to Present at the LD Micro Virtual Invitational Conference on June 10, 2021

PR Newswire June 2, 2021

Health Monitor Network Expands Senior Leadership Team in Response to Continued Growth

PR Newswire June 2, 2021

AbbVie to Present Analysis Evaluating Continuous RINVOQ® (upadacitinib) Treatment in Psoriatic Arthritis for More Than One Year at EULAR 2021 Virtual Congress

PR Newswire June 2, 2021

DocGo to Participate at the Stifel 2021 Virtual Cross Sector Insight Conference

PR Newswire June 2, 2021

MorphImmune, Inc. Appoints Ronald Martell as President and CEO

PR Newswire June 2, 2021

Provention Bio Announces the Grant of Inducement Awards

PR Newswire June 2, 2021

Kedrion and Kamada Announce FDA Approval of KEDRAB® Label Update, Confirming Safety and Effectiveness in Children

PR Newswire June 2, 2021

Karyopharm Receives Conditional Marketing Authorization in the United Kingdom (UK) for NEXPOVIO® (selinexor) in Combination with Dexamethasone for the Treatment of Adult Patients with Relapsed and or Refractory Multiple Myeloma

PR Newswire June 2, 2021

Samsung Biologics and KAHR Medical Announce Development and Manufacturing Agreement for Cancer Immunotherapy Drug Candidate

PR Newswire June 2, 2021

WELL's DoctorCare Completes Majority Stake Acquisition of Doctors Services Group

PR Newswire June 2, 2021